Ampio Pharmaceuticals, Inc. (AMPE)

Ampio Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	0	2	3	114	275	82
Market Cap Growth	-50.93%	-52.09%	-96.95%	-58.66%	233.20%	83.35%
Enterprise Value	-4	-2	-9	81	259	77
PE Ratio	-	-0.19	-0.41	-9.10	-16.66	-9.50
PB Ratio	0.03	0.49	0.29	4.16	15.69	12.80
P/FCF Ratio	-0.20	-0.19	-0.16	-8.01	-18.58	-5.35
P/OCF Ratio	-0.20	-0.19	-0.16	-8.06	-18.66	-5.36
EV/EBITDA Ratio	0.23	0.23	0.37	-3.35	-18.42	-3.49
EV/EBIT Ratio	0.22	0.23	0.35	-3.21	-17.00	-3.30
EV/FCF Ratio	0.25	0.25	0.41	-5.68	-17.49	-5.03
Debt / Equity Ratio	0.08	0.08	0.05	0.03	0.07	0.23
Debt / EBITDA Ratio	-0.03	-0.03	-0.03	-0.04	-0.09	-0.07
Debt / FCF Ratio	-0.03	-0.03	-0.03	-0.07	-0.08	-0.10
Quick Ratio	2.11	2.11	10.61	6.62	9.56	1.53
Current Ratio	2.36	2.36	11.18	6.96	10.08	1.93
Interest Coverage	0	0	3.08	0	0	-304.48
Return on Equity (ROE)	-247.89%	-256.90%	-71.82%	-45.76%	-94.21%	-134.78%
Return on Assets (ROA)	-145.21%	-150.49%	-62.31%	-32.16%	-72.11%	-62.02%
Return on Capital (ROIC)	-250.30%	-261.92%	-195.17%	-89.18%	-81.29%	-296.32%
Earnings Yield	-7336.00%	-519.77%	-244.24%	-10.99%	-6.00%	-10.53%
FCF Yield	-7542.98%	-515.68%	-609.47%	-12.49%	-5.38%	-18.68%
Buyback Yield / Dilution	-10.11%	-7.50%	-12.23%	-12.78%	-25.61%	-23.29%
Total Shareholder Return	-10.11%	-7.50%	-12.23%	-12.78%	-25.61%	-23.29%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.